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Abstract
Purpose This study aimed at evaluating the comorbidity
between DSM-IV obsessive compulsive disorder (OCD) and
subthreshold forms and physical diseases in the general
population as well as disability associated with comorbidity.
Methods We used data from the 1998 German Mental
Health Survey, a representative survey of the German popu-
lation. Mental disorders and physical diseases of 4181 subjects
(aged 18–65) were cross-sectionally assessed. Mental disor-
ders were diagnosed using the M-CIDI/DIA-X interview.
Physical diseases were assessed through a self-report ques-
tionnaire and a standardized medical interview. We created
three groups of obsessive–compulsive symptoms: (1) no
obsessive compulsive symptoms (n = 3,571); (2) obsessive
compulsive symptoms (OCS, n = 371; endorsement of OCS
(either obsession or compulsion) without fulfilling any core
DSM-IV criteria); (3) subthreshold OCD/OCD (n = 239;
fulfilling either some or all of the core DSM-IV criteria).
Results In comparison to subjects without OCS, subjects
with subthreshold OCD/OCD showed higher prevalence rates
of migraine headaches (OR 1.7; 95 % CI 1.1–2.5) and respi-
ratory diseases (OR 1.7; 95 % CI 1.03–2.7); subjects with OCS
showed higher prevalence rates of allergies (OR 1.6; 95 % CI
1.1–2.8), migraine headaches (OR 1.9; 95 % CI 1.4–2.7) and
thyroid disorders (OR 1.4; 95 % CI 1.01–2.0). Subjects with
both OCS and physical disease reported the highest number of
days of disability due to physical or psychological problems
during the past 30 days compared to subjects with only OCS,
only physical disease or neither of them.
Conclusions OCD and subthreshold forms are associated
with higher comorbidity rates with specific physical diseases
and higher disability than subjects without OCS. Possible
etiological pathways should be evaluated in future studies
and clinicians in primary care should be aware of these
associations.
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Abbreviations
OCD Obsessive compulsive disorder
OCS Obsessive compulsive symptoms
GHS-MHS German health interview and examination
survey and its mental health supplement
DIA-X/M-CIDI The Munich composite international
diagnostic interview
DSM-IV Diagnostic and statistical manual of
mental disorders, Fourth Edition
ICD-10 International classification of diseases,
Tenth Edition
CI Confidence interval
OR Odds ratio
IRR Incidence risk ratio
RERI Relative excess risk due to interaction
AP The attributable proportion due to
interaction
S Synergy index
Introduction
There is increasing evidence that mental disorders fre-
quently co-occur with physical diseases [1–4]. Such
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comorbidity between mental and physical diseases has
been found in patients diagnosed with schizophrenia,
bipolar disorder, schizoaffective disorder and major
depressive disorder [5]. Among these patients, nutritional
and metabolic diseases, cardiovascular diseases, viral dis-
eases, respiratory tract diseases, musculoskeletal diseases,
pregnancy complications and stomatognathic diseases were
found to be more prevalent than in the general population
[1, 6, 7]. Due to their higher risk of cardiovascular diseases,
patients with affective disorders are even known to be at
high risk for premature death [4, 8].
There is evidence from patients and community-based
studies that physical health problems are also associated
with anxiety disorders [2, 3, 9, 10]. Significant associations
between anxiety disorders and cardiac disorders, hyper-
tension, gastrointestinal problems, genitourinary disorders
and migraine have been found in patients recruited from
treatment and community sources [2]. Additionally,
increased rates of arthritis, asthma and ulcers were detected
in patients with anxiety disorders [10]. Likewise, popula-
tion surveys showed that depressive and anxiety disorders
without comorbidity were associated in equal degree with
physical conditions [3]. In addition, analyses revealed that
the presence of an anxiety disorder was significantly
associated with thyroid disease, respiratory disease, gas-
trointestinal disease, arthritis, migraine headaches and
allergic conditions in the general population [9]. Even
community samples across different countries showed that
anxiety disorders occurred at higher rates in persons with
heart diseases compared to those without heart disease
[11]. Moreover, community analyses revealed that specific
anxiety disorders are also significantly associated with
medically explained pain symptoms, unexplained pain
symptoms and pain disorder [12].
This mental-physical comorbidity has negative conse-
quences for subjects’ disability in daily life. Subjects with
comorbid physical and anxiety disorders are more likely to
be severely disabled than subjects with either condition
alone [9, 13, 14]. This may suggest that it should be
ensured that subjects with mental-physical comorbidity
receive enough clinical care in order to recognize and treat
both disorders.
Additionally, cross-sectional analyses of the association
of specific physical diseases with certain mental disorders
can lead to hypotheses concerning etiological mechanisms
at least in subgroups of affected subjects. For example,
asthma has been found to be associated with panic disorder
in many cross-sectional community-based studies [15].
These findings stimulated longitudinal studies to evaluate
the role of smoking as an etiological factor in asthma and
panic disorder [15]. This illustrates how hypotheses of
certain etiological factors can be derived from cross-sec-
tional associations of mental-physical comorbidity.
Based on the fact that several studies showed associa-
tions between many mental disorders and specific physical
diseases, we will report for the first time the association of
specific physical diseases and OCD and disability related to
this comorbidity. This is important because epidemiologi-
cal studies showed that across anxiety disorders obsessive
compulsive disorder (OCD) was found to be the disorder
with the highest estimate of the number of life years lost
due to the disease in men and second highest in women
behind panic disorder [16]. Increased health care utilization
among individuals with OCD [17] and decreased physical
wellbeing (referring to physical health, sleep and pain) in
patients with OCD [18] were found. Additionally, one
study revealed that the presence of any chronic physical
condition increases the prevalence of obsessive–compul-
sive symptoms [19]. Furthermore, it is known that sub-
threshold types of OCD that do not fulfill all DSM-IV
diagnostic criteria are more prevalent in the general pop-
ulation compared to OCD [20–22]. Adam et al. [17] could
show that subjects with such ‘‘subthreshold’’ OCD (i.e.
fulfilling some but not all core DSM-IV criteria) and
obsessive compulsive symptoms (i.e. endorsement of stem
questions without fulfilling any core DSM-IV criteria)
report higher disability and increased health care utilization
in the community than subjects without these symptoms.
To our knowledge no community study about the
physical health problems of individuals with OCD and
subthreshold forms has been published, even though sub-
threshold forms of OCD are known to be associated with
comparable disability as full diagnostic OCD. As shown
above, these analyses are relevant for implications of the
health care system and to generate etiological hypotheses
of OCD.
In this report we, therefore, evaluate the association
between physical diseases and individuals with OCD and
subthreshold forms in the general population and the dis-
ability associated with comorbidity. For this purpose we
use representative community data from the German
Health Interview and Examination Survey and its Mental
Health Supplement.
Method
Design and sample
We used Data from the German Health Interview and
Examination Survey and its Mental Health Supplement
(GHS-MHS) conducted in 1997. The GHS was the first
nationwide cross-sectional study for medical and social
assessments in Germany and was commissioned by the
German Ministry of Science, Research and Education and
the Robert Koch Institute and authorized by the relevant
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institutional review board and ethics committee. The aim
of the core study was the assessment of sociodemographic
characteristics, physical diseases, impairments and health-
care utilization in a representative community sample of
7,124 subjects aged 18–79 (overall response rate 61.5 %).
It was a stratified, randomized sample from 113 commu-
nities throughout Germany with 130 sampling units (sam-
pling steps: (1) selection of communities, (2) selection of
sampling units, (3) selection of inhabitants) [23, 24]. To
handle the stratified sampling design the data were
weighted and confidence intervals were calculated by the
Huber-White sandwich method to account for the weight-
ing scheme as well as the stratified sampling design [24].
For the assessment of mental disorders in the GHS-
MHS, a two-stage design was used: The first stage entailed
the administration of a 12-item screening questionnaire for
mental disorders at the end of the medical examination of
the core survey (CID-S) [25]. The second stage involved
the administration of a structured psychopathological
interview, the Munich Composite International Diagnostic
Interview (DIA-X/M-CIDI), to all core survey subjects
who had screened positive for a mental disorder and to a
random sample of 50 % who screened negative [25]. This
subsample of the GHS built the sample of the Mental
Health Supplement and included 4,181 subjects aged
18–65 years. The conditional response rate (i.e., subjects
who completed the M-CIDI interview) was 87.6 %. All
subjects gave their informed consent. Further description of
aims, design and methods as well as sociodemographic
characteristics of the whole GHS-MHS sample can be
found elsewhere [23].
Assessment of OCD
For the diagnostic assessments, a modified version of the
fully structured interview DIA-X/M-CIDI was used [26].
The questions covered DSM-IV and ICD-10 criteria. The
DIA-X interview enables the assessments of symptoms,
syndromes and onset, duration and severity. The interview
was conducted by trained psychologists and physicians
[27]. The test–retest reliability for OCD was found to be
excellent (k = 0.81) with an average time interval of
38 days between interviews in a sample of 60 subjects in
the community. The validity of the DIA-X/M-CIDI OCD
diagnoses compared to diagnoses from independent treat-
ing physicians in a sample of 68 randomly chosen patients
was also excellent (k = 0.91). The sensitivity was 100 %,
while the specificity was 98.4 % [17, 28].
The DIA-X/M-CIDI module for OCD includes two
parts: one for the assessment of obsessions and one for the
assessment of compulsions. In each part, stem questions are
asked at the beginning. In the obsession section the stem
question refers to a wide range of potential thoughts and
cognitions presented in the form of a symptom list:
‘‘During the last 12 month, have you been bothered by
having certain unpleasant thoughts or images like recurrent
arbitrary thoughts, such as the idea that your hands are
dirty or have germs on them?’’ (yes or no). In the com-
pulsion section three stem questions are asked to assess
repetitive behaviors (‘‘doing something like washing hands
over and over again (yes or no) or ‘‘checking several times
whether the door is locked’’ (yes or no) or mental acts
(‘‘counting something like tiles in a floor’’ (yes or no)). If
the subject approves one of these stem questions, they are
subsequently asked for the mandatory DSM-IV criteria.
The DSM-IV mandatory criteria include criteria A for the
diagnostic details of obsessions and compulsions, criteria B
for the recognition that the obsessions or compulsions are
excessive or unreasonable and C for the evaluation if the
disorder causes distress or dysfunction. Diagnostic criteria
refer to the past 12 months.
To facilitate comparisons with prior work [17], this
paper splits the sample into the following three mutually
exclusive groups:
1. Subthreshold OCD/OCD (either (a) subthreshold
OCD: the subject affirmed at least one of the stem
questions for obsessive or compulsive symptoms and
fulfilled at least one of the DSM-IV diagnostic criteria
A, B or C, but not the full DSM-IV criteria, or
(b) OCD: the subject met full DSM-IV criteria A, B
and C for OCD)
2. OCS (the subject affirmed at least one of the stem
questions for obsessive or compulsive symptoms, but
did not fulfill any of the DSM-IV criteria A, B or C)
3. No OCS (the subject did not affirm any of the stem
questions for obsessions or compulsions)
Due to the small group size of full diagnostic OCD (see
Table 1) and the small cell sizes when combined with
physical diseases, we merged the groups OCD and sub-
threshold OCD (group 1) in contrast to Adam et al. [17].
Assessment of physical conditions
In the GHS, physical conditions were assessed by a self-
report questionnaire and a standardized computer-assisted
medical interview by a general practice physician.
Based on the information on physical diseases in the
self-report questionnaire, the physicians conducted infor-
mation about lifetime prevalences, 12-month prevalences
and point prevalences (4 weeks) of 44 physical diseases
[23].
Additionally anthropometric and blood pressure mea-
surements were conducted as well as blood and urine
samples. Based on these laboratory analyses diagnoses
were then supplemented and revised [23]. The following
Soc Psychiatry Psychiatr Epidemiol (2014) 49:2013–2022 2015
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analyses are based on the physicians’ diagnoses during the
medical interview. We, therefore, grouped the disorders
into eleven groups of disorders (see Table 1).
Assessment of disability
Disability was assessed by asking the subjects whether he
or she was completely or partially unable to carry out daily
activities (i.e., function in work, in school or in family),
because of psychological problems in the 4 weeks before
the interview took place (yes or no) and whether he or she
was completely or partially unable to carry out daily
activities (function in work, in school or in family),
because of physical problems in the 4 weeks before the
interview took place (yes or no).
Sociodemographic correlates
For the present sample, earlier analyses revealed no asso-
ciations between OCS, subthreshold OCD, OCD and gen-
der, employment status and social class [17]. Significant
associations between age and subthreshold OCD and OCS
were found: the 12-month prevalence was lower in the
older age group. Additionally, the 12-month prevalence of
OCS was higher in the separated, divorced or widowed
subjects group. More details can be seen elsewhere [17].
Statistical analyses
Comorbidity between OCS and physical diseases
We used logistic regression [odds ratio (OR) with 95 %
confidence intervals (CI)] to examine associations between
the groups OCS and subthreshold OCD/OCD and physical
diseases. We considered a p value \0.05 as statistically
significant. For the logistic regression analyses we used the
STATA software package, version 11.0 [29].
Disability
To analyze the association between OCS and physical
disease on the risk of physical or psychological disability
we used the two factors OCS (combining both OCS
groups) and physical disease (which includes any of the
physical diseases), both having two levels (yes or no). To
determine whether comorbidity of OCS and physical dis-
ease were associated with an increased likelihood of past
30-day disability due to physical or psychological prob-
lems, we considered the zero inflated negative binomial
model and the Hurdle model as these models account for
excessive zeros (85.8 % of subjects reported 0 days of
disability due to physical problems and 98.7 % of subjects
reported 0 days of disability due to psychological prob-
lems). These two models led to almost identical results and
fitted the data equally well (based on the Akaike infor-
mation criterion, AIC). We chose the Hurdle model
because we think that its underlying process is somewhat
more comprehensible compared with the zero inflated
negative binomial model. The hurdle model (OR with
95 % CI and incidence risk ratio (IRR) with 95 % CI)
assumes negative binomial (physical disability) or Poisson
(psychological disability) distributed outcomes. This model
accounts not only for the excessive number of zeros
observed, but also for overdispersion (i.e. the fact that the
observed variability in the outcome was higher than its
mean, see e.g. [30]). Hurdle models consist of two parts. In
the first part, a binomial model is used to model the
probability of zeros versus non-zeros. In the second part
that deals with the non-zero counts and which is hence
often called the ‘‘count model’’, a Poisson or a negative
binomial model is used (depending on whether the counts
are over dispersed or not). As only non-zero values are
considered in this second part, this model is zero-truncated
[31].
Our model contained the two factors OCS and physical
disease plus the interaction between the two. For both
factors we were thus able to test (1) whether they had an
Table 1 12-month prevalences of no OCS, OCS and subthreshold
OCD/OCD and physical diseases in the total sample (n = 4,181)
No. (%)
no OCS 3,571 (86.5)
OCS 371 (8.3)
Subthreshold OCD/OCD 239 (5.2)
Subthreshold OCD 201 (4.5)
OCD 38 (0.7)
Hypertension 581 (13.1)
Cardiac diseases (heart circulation disturbances,
Narrowing of the coronary vessels, angina, pectoris,
cardiac infarct, heart weakness, heart, insufficiency)
100 (2.2)
Respiratory diseases (asthma, chronic bronchitis) 284 (7.0)
Gastrointestinal diseases (ulcer, gastritis) 268 (6.3)
Diabetes (with or without insulin treatment) 115 (2.7)
Arthritic conditions (wear and tear type, inflammatory
diseases of the joints)
1,107 (25.9)
Allergies (hay fever, allergic eczema, allergic hives,
neurodermatitis, food allergy, allergic conjunctivitis)
747 (18.1)
Migraine headaches 491 (10.3)
Neurological diseases (epilepsy, parkinson disease,
multiple sclerosis)
27 (0.5)
Thyroid diseases 445 (10.0)
Vascular diseases (stroke, brain circulation
disturbance, leg circulation disturbances, artery
occlusion, varicose veins, vein thrombosis)
536 (12.4)
OCS obsessive–compulsive symptoms, OCD obsessive–compulsive
disorder, No. unweighted number of subjects, % weighted percentage
2016 Soc Psychiatry Psychiatr Epidemiol (2014) 49:2013–2022
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impact on the probability of physical or psychological
disability and (2) whether they affected the number of days
of disability among those subjects who have reported at
least 1 day of disability. The interaction thereby tested
whether subjects having both OCS and physical disease
were (1) at a particularly high risk of physical or psycho-
logical impairment and (2) if so, how strongly. For calcu-
lating the hurdle model we used the software MPlus
(version 6) [32].
To check for biological interaction as described by Roth-
man [33], i.e. whether the combined effect of both factors OCS
and physical disease is larger than the sum of the individual
effects of these two factors, denoting deviation from additivity
in disease risks, we additionally calculated the relative excess
risk due to interaction (RERI), the attributable proportion due
to interaction (AP) and the synergy index (S) [34], using the
software R (version 2.14) [35]. Absence of biological inter-
action thereby suggests independence of OCS and physical
disease as risk factors of disability.
Results
12-month prevalence
The 12-month prevalence rate was 8.3 % for OCS, and
5.2 % for the combined OCD and subthreshold OCD
(Table 1). Among physical diseases, the highest 12-month
prevalence rate was detected for arthritic conditions
(25.9 %), the lowest for neurological diseases (0.5 %).
Associations of physical diseases and OCS,
subthreshold OCD/OCD
Significantly higher prevalence rates in subjects with OCS
were found for allergies (OR 1.6; 95 % CI 1.1–2.8),
migraine (OR 1.9; 95 % CI 1.4–2.7) and thyroid diseases
(OR 1.4; 95 % CI 1.01–2.0) compared to the no OCS group
(see Table 2).
The subthreshold OCD/OCD group was associated with
elevated odds for respiratory diseases (OR 1.7; 95 % CI
1.03–2.7) and migraine (OR 1.7; 95 % CI 1.1–2.5).
Disability
Disability due to physical problems
We used the two factors OCS (combining both OCS
groups) and physical disease (which includes any of the
physical diseases) to analyze the association with disabil-
ity. As there was no indication of statistical interaction
between the two factors for both the binomial (p = 0.40)
and the count model parts (p = 0.77), we reran the model
without interaction. The binomial part of the model
revealed that both OCS and physical disease significantly
increased the probability of disability (OCS: OR 1.9; 95 %
CI 1.4–2.5, p \ 0.001; physical disease: OR 1.7; 95 % CI
1.2–2.2, p \ 0.001). The count model part of the model
showed that physical disease significantly increased the
number of days of disability (IRR 1.6; 95 % CI 1.1–2.2,
p = 0.008), whereas OCS did not (IRR 1.3; 95 % CI
0.9–1.8, p = 0.064).
As shown in Fig. 1, the highest number of days of dis-
ability due to physical diseases was reported by subjects
with both OCS and physical disease (n = 95 (2.74 %),
M 2.33; 95 % CI 1.61–3.05), followed by subjects with
OCS only (M 1.10; 95 % CI 0.64–1.55) and by subjects
with physical disease only (M 1.09; 95 % CI 0.86–1.34).
Subjects with neither OCS nor physical disease indicated
the lowest number of days of disability (M 0.50; 95 % CI
0.3–0.7). There was no indication for the presence of bio-
logical interaction for any of the three measures (SI, RERI,
AP; p [ 0.05 in each case).
Disability due to psychological problems
As there was no indication of statistical interaction between
the two factors for both the binomial (p = 0.24) and the
count model parts (p = 0.74) in the disability due to psy-
chological problems, we again reran the model without the
interaction. The binomial part of the model revealed that
both OCS and physical disease significantly increased the
probability of disability (OCS: OR 3.8; 95 % CI 2.1–6.9,
p \ 0.01; physical disease: OR 3.7; 95 % CI 1.4–9.8,
p \ 0.01). Contrary to the disability due to physical
problems, the count model part of the model revealed that
there was no significant effect of both factors on the
number of days of disability due to psychological problems
(p [ 0.55 for both model parts).
As for disability due to physical problems, the highest
number of days of disability due to psychological problems
was reported by subjects with both OCS and physical
disease (n = 19 (0.55 %), M 0.47; 95 % CI 0.17–0.76),
followed by subjects with OCS only (M 0.14; 95 % CI
0.03–0.31) and by subjects with physical disease only
(M 0.10; 95 % CI 0.05–0.16). Subjects with neither OCS
nor physical disease indicated the lowest number of dis-
ability days (M 0.03; 95 % CI 0.00–0.06; Fig. 1). Again, no
indication for biological interaction was found for any of
the three measures (SI, RERI, AP; p [ 0.05 in each case).
Discussion
To the best of our knowledge, this is the first study that
analyses the association between OCD and subthreshold
Soc Psychiatry Psychiatr Epidemiol (2014) 49:2013–2022 2017
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Table 2 Associations between
12 months physical diseases and
12-months obsessive–
compulsive symptoms and
disorder
OR odds ratios from logistic
regression, CI confidence
intervals, OCS obsessive–
compulsive symptoms, OCD
obsessive–compulsive disorder,
No. unweighted number of
subjects, % weighted percentage
* p \ 0.05
a Subjects reporting physical
diseases during their lifetime
but not within the past
12 months were excluded from
the analyses
Physical diseasesa no OCS
(n = 3,571)
OCS
(n = 371)
Subthreshold OCD/OCD
(n = 239)
No. % No. (%) OR (CI) No. (%) OR (CI)
Hypertension
No hypertension (n = 3,372) 2,868 (81.6) 303 (83.5) 1.0 201 (87.4) 1.0
Hypertension (n = 581) 513 (13.7) 43 (9.7) 0.7 (0.4–1.0) 25 (8.7) 0.6 (0.3–1.0)
Cardiac diseases
No cardiac diseases (n = 3,982) 3,394 (95.6) 358 (97.5) 1.0 230 (95.6) 1.0
Cardiac diseases (n = 100) 89 (2.3) 6 (1.3) 0.6 (0.2–1.4) 5 (2.8) 1.2 (0.4–3.5)
Respiratory diseases
No respiratory diseases
(n = 3,728)
3,201 (89.6) 321 (87.6) 1.0 206 (85.6) 1.0
Respiratory diseases (n = 284) 234 (6.8) 26 (6.7) 1.0 (0.6–1.6) 24 (10.8) 1.7
(1.03–2.7)*
Gastrointestinal diseases
No gastrointestinal diseases
(n = 3,090)
2,264 (75.5) 263 (71.3) 1.0 163 (68.3) 1.0
Gastrointestinal diseases
(n = 268)
215 (6.1) 29 (7.2) 1.3 (0.8–2.0) 24 (8.7) 1.6 (0.9–2.7)
Diabetes
No diabetes (n = 4,022) 3,430 (96.5) 360 (97.2) 1.0 232 (97.2) 1.0
Diabetes (n = 115) 102 (2.8) 7 (2.2) 0.8 (0.3–1.8) 6 (2.4) 0.9 (0.3–2.5)
Arthritic conditions
No arthritic conditions
(n = 2,907)
2,495 (70.7) 248 (69.0) 1.0 164 (70.6) 1.0
Arthritic conditions (n = 1,107) 938 (25.8) 107 (27.9) 1.1 (0.8–1.5) 62 (25.1) 1.0 (0.7–1.4)
Allergies
No allergies (n = 2,682) 2,334 (65.6) 207 (54.3) 1.0 141 (58.3) 1.0
Allergies (n = 747) 614 (17.3) 81 (23.5) 1.6
(1.1–2.8)*
52 (21.9) 1.4 (0.9–2.1)
Migraine
No migraine (n = 3,497) 3,016 (86.5) 292 (80.8) 1.0 189 (80.9) 1.0
Migraine (n = 491) 384 (9.5) 68 (17.0) 1.9
(1.4–2.7)*
39 (14.6) 1.7
(1.1–2.5)*
Neurological diseases
No neurological diseases
(n = 4,114)
3,517 (99.0) 362 (98.3) 1.0 235 (98.2) 1.0
Neurological diseases (n = 27) 21 (0.5) 4 (0.9) 1.9 (0.6–5.8) 2 (0.9) 2.0 (0.4–9.7)
Thyroid diseases
No thyroid diseases (n = 3,451) 2,973 (84.8) 284 (77.6) 1.0 194 (82.1) 1.0
Thyroid diseases (n = 445) 367 (9.7) 49 (12.6) 1.4
(1.01–2.0)*
29 (11.0) 1.2 (0.7–1.9)
Vascular diseases
No vascular diseases
(n = 3,351)
2,859 (81.1) 302 (82.8) 1.0 190 (80.8) 1.0
Vascular diseases (n = 536) 459 (12.5) 42 (11.2) 0.9 (0.5–1.4) 35 (13.7) 1.1 (0.7–1.7)
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forms and physical diseases in a representative community
sample.
Our results show that obsessive compulsive symptoms are
associated with higher prevalence rates of specific physical
diseases in the general population. These results add to the
body of literature on the comorbidity of physical diseases
and other anxiety disorders. In comparison to findings from
other anxiety disorders, we found associations with migraine
headaches, allergies and thyroid diseases in OCS and sig-
nificant associations with respiratory diseases and migraine
headaches in subthreshold OCD/OCD [2, 9, 10]. Further, our
analyses revealed that subjects with both OCS and physical
disease report the highest number of days of disability
compared to subjects having only OCS (without physical
disease), only a physical disease or neither of them.
Different models exist to explain the cooccurrence of
anxiety disorders and physical diseases: anxiety as conse-
quent or antecedent factor of a physical disease, third
variables that lead to the comorbidity or, common genetic,
environmental or personality factors that contribute to the
cooccurrence [9]. Even though only few specific hints for
the explanations of associations between OCS and physical
diseases exist, these hints can point towards important
etiological pathways in subgroups of OCD patients and,
therefore, will be discussed in the following.
First, defects in serotonin metabolism as possible neu-
rochemical basis of both migraine and OCD have been
proposed [36]. An abnormal serotonin function in subjects
with OCD is one of the most consistent pathophysiologic
findings [37]. Similarly, serotonin abnormalities have been
implicated in the pathogenesis of migraine [36, 38].
Alternatively it has been proposed that anxiety disorders
may be involved in peripheral and central mechanisms of
pain sensitization which contributes to the evolution of
chronic headaches [39]. Against this background, our
results can support a suggested role of serotonin in an
etiological pathway of OCD.
Second, an increased rate of immune-related symptoms
among OCD patients has been reported [40]. As a possible
explanation, one theory suggests that postinfectious auto-
immune responses might be associated with the develop-
ment of pediatric OCD, which leads to an increased rate of
immune-related diseases in adults with OCD [40]. Our
cross-sectional results match with this theory, as we found
increased rates of allergies in subjects with OCS. Studies
showed that especially immune responses to streptococcal
infections may be relevant for the etiology of OCD [41].
Our analyses support a suggested involvement of immune
responses that may be relevant in the etiology of a sub-
group of OCD.
Third, the association between asthma and anxiety dis-
orders, especially in panic disorder, is well established [42,
43]. Explanations range from hyperventilation that is
commonly associated with anxiety disorders, subjective
psychological disturbance which could lead to enhanced
bronchoconstriction to biological effects of anxiety on
immunological or biological factors [44]. Specific expla-
nations of the association between OCD and respiratory
diseases lack, however. Therefore, we can only speculate
that comparable to other anxiety disorders, subjects with
OCD could have an altered symptom perception leading to
enhanced awareness of breathlessness and bronchocon-
striction and therefore to asthma-like symptoms. Despite
that no specific explanation for this association exists, our
results nevertheless show that an involvement of the
respiratory tract may be important in OCD.
Fourth, pervasive evidence documents the relationship
between thyroid diseases and mental symptoms such as
impairment of cognitive functions or behavioral and mood
disturbances [45, 46]. Concerning OCD, some observations
of increased rates of obsessive–compulsive symptoms in
subjects with thyroid disease have been found [46]. As an
explanation, common biochemical abnormalities that play
a role for both thyroid diseases and OCD may exist [46]. A
Fig. 1 Mean days of disability
during past 30 days. OCS
obsessive compulsive
symptoms; Error bars indicate
standard errors
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diminished thyrotropin releasing hormone (TRH) response
to a TRH stimulation was detected in subjects with OCD,
also [47] suggesting an alteration in the serotonergic sys-
tem, as a decreased central serotonergic activity is associ-
ated with blunted TSH response [47]. The increased rates
of thyroid diseases in our analyses support the hypothesis
of an alteration of the hypothalamic-pituitary-thyroid axis
in the pathophysiology of OCD, too.
Fifth, it could be suggested that certain behaviors that
occur in OCD increase the vulnerability to develop a
physical disease. As a lack of exercise has been associated
with anxiety disorders [48] and physical inactivity is
associated with many chronic physical diseases such as
cardiovascular diseases or diabetes [49], it could be sug-
gested that subjects with OCD are at increased risk to
develop physical illnesses through physical inactivity.
Further, it has been shown that cleaning activities related to
exposure to certain cleaning products in the household are
associated with asthma [50]. Extensive hand washing or
cleaning can be a symptom of OCD. Through exposure to
poisonous cleaning agents this could lead to higher prev-
alence of respiratory diseases in subjects with OCD.
Additionally, subjects with OCD avoid uncertainty [51].
This might in addition be related to an increased preva-
lence of physical diseases in these subjects, as isolation
and, therefore, a lack of exercise may be the consequences.
Given these etiological considerations, our results may
be useful to deduce hypotheses concerning the involvement
of certain physiological factors in the etiology of OCD in
subgroups of subjects. Future studies are clearly needed to
replicate these findings.
As some physical diseases were only associated with
OCS and not OCD (higher prevalence of allergies and
thyroid diseases only in OCS) or vice versa, it is possible
that different etiological factors are related to OCS, sub-
threshold OCD and OCD. Future studies should, therefore,
not only include OCD but also subthreshold forms to test
these hypotheses.
Besides the documentation of the associations between
physical diseases and OCS and the deduction of potential
etiological hypotheses, our analyses show that both sub-
jects with OCS or physical diseases have an increased
probability of disability due to psychological or physical
problems during the past 30 days. Comparable to previous
studies on anxiety disorders [9] or mental disorders in
general [13] and physical diseases, the highest number of
days of disability was reported in the group with both OCS
and physical diseases. This is supported by previous find-
ings that subjects with both mental and physical conditions
are more likely to be severely disabled than those with
either condition alone [13].
Due to the fact that no indication for biological inter-
action was found between OCS and physical disease, the
increased disability of subjects affected by both OCS and
physical disease may be seen as an additive rather than a
synergistic effect of both disorders.
The mechanisms leading to this specific increased dis-
ability are unknown. Research on other anxiety disorders,
however, suggest that anxiety is associated with poor
adherence to self-care regimen and increased medical
complications in patients with chronic medical illness [52].
This could lead to decreased active behavioral self-man-
agement strategies and, therefore, to an increased burden of
the physical disease in anxiety in general [53] and specif-
ically in OCD.
The increased disability in subjects with both OCS and
physical disease may reflect an increased need of recog-
nition and treatment of both physical disorder and OCS in
primary health care. Future studies could additionally
investigate whether this comorbidity is associated with a
loss in quality of life.
The current study has a number of limitations. First,
the survey is limited to subjects aged 18–65 years, which
does not enable generalization of the results to younger or
older subjects. Second, as already mentioned by Sareen
et al. [9], even though physicians’ diagnoses were used,
certain diagnoses are more reliant on self-report data (e.g.
arthritis) than others (e.g. diabetes). That may have led to
over reporting of physical symptoms in anxious patients.
Third, due to the cross-sectional nature of the study, it is
not possible to draw conclusions about the causal nature
of the associations between OCD or OCS and physical
diseases. Fourth, although we used a large representative
sample with 4,181 subjects, the sample size of full
diagnostic OCD is rather small (n = 38). In addition, the
combinations between OCD symptoms and physical dis-
eases led to small cell sizes (especially in cardiac dis-
eases, diabetes and neurological diseases). Fifth, it has to
be considered that comorbidity between OCD and sub-
threshold forms and other mental disorders has been
reported [17]. Thus, further investigation is needed to
examine specificity of the results.
With these limitations in mind, our community study
shows that subjects affected by DSM-IV obsessive com-
pulsive disorder either on the full/subthreshold or even on
the symptomatic level report higher rates of certain phys-
ical diseases than subjects without these symptoms. This
comorbidity is associated with higher impairment than
either condition alone.
These findings can be helpful to detect new etiological
pathways underlying OCD in subgroups of affected sub-
jects or support the ones suggested in earlier studies. In
addition, clinicians and doctors in primary care need to be
sensibilized for these associations to recognize and treat
both physical disease and OCS to reduce disability in
affected subjects.
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